[Purpose] Spondyloarthritis is a major inflammatory disease followed-up in the rheumatology clinics, foot involvement in spodyloarthritis is common. The functional states of patients with spondyloarthritis are usually evaluated globally. The aim of this study was to assess the foot involvement-related functional limitations in patients with spondyloarthritis. [Subjects and Methods] Patients with ankylosing spondylitis and psoriatic arthritis with foot pain more than 4 weeks who underwent anteroposterior and lateral feet radiography were enrolled into the study. A "clinical findings score" was calculated by assigning 1 point for every finding of swelling, redness, and tenderness. C-reactive protein and erythrocyte sedimentation rate were used as serum markers for disease activity. Foot radiograms were evaluated using the spondyloarthropathy tarsal radiographic index and the foot-related functional state of patients was determined by the Turkish version of the Foot and Ankle Outcome Score. [Results] There were no relationships between Foot and Ankle Outcome Score subscales and clinical findings score, serum markers, or radiologic score. Pain and symptoms subscale scores were result positively correlated with activity of daily living, sport and recreation, and quality of life subscale scores. [Conclusion] Pain and symptoms are the main determinants of foot-related functional limitations in spondyloarthritis.
[Purpose]Spondyloarthritis is a major inflammatory disease followed-up in the rheumatology clinics, foot involvement in spodyloarthritis is common. The functional states of patients with spondyloarthritis are usually evaluated globally. The aim of this study was to assess the foot involvement-related functional limitations in patients with spondyloarthritis. [Subjects and Methods]Patients with ankylosing spondylitis and psoriatic arthritis with foot pain more than 4 weeks who underwent anteroposterior and lateral feet radiography were enrolled into the study. A "clinical findings score" was calculated by assigning 1 point for every finding of swelling, redness, and tenderness. C-reactive protein and erythrocyte sedimentation rate were used as serum markers for disease activity. Foot radiograms were evaluated using the spondyloarthropathy tarsal radiographic index and the foot-related functional state of patients was determined by the Turkish version of the Foot and Ankle Outcome Score. [Results] There were no relationships between Foot and Ankle Outcome Score subscales and clinical findings score, serum markers, or radiologic score. Pain and symptoms subscale scores were result positively correlated with activity of daily living, sport and recreation, and quality of life subscale scores. [Conclusion]Pain and symptoms are the main determinants of foot-related functional limitations in spondyloarthritis.
Entities:
Keywords:
Foot; Foot and Ankle Outcome Score; Spondyloarthritis
Spondyloarthritis (SpA) is a group of rheumatic diseases characterized by inflammatory back
pain, peripheral oligoarthritis, enthesitis, and/or extraarticular manifestations1). Ankylosing spondylitis (AS) and psoriatic
arthritis (PsA) are the most frequently seen SpA subtypes in rheumatology units2,3,4). Foot involvement in SpA is not uncommon and
enthesitis, erosive changes, or ankylosis are the main symptoms5, 6). This involvement
may affect foot functions negatively, similar to rheumatoid arthritis (RA)7). In rheumatology units, the functional
states of patients with SpA are usually evaluated using Bath Ankylosing Spondylitis
Functional Index (BASFI) or other similar scales globally. However, these assessments may
underestimate the foot-related functional limitations in these patients.The Foot and Ankle Outcome Score (FAOS) is a scale measuring the foot-related functional
limitations in the disorders affecting the foot7,8,9,10). It consists of 5 subscales: pain,
symptoms, activities of daily living (ADL), function in sport and recreation (Sport-Rec),
and foot and ankle-related quality of life (QoL). The Turkish version of FAOS is a valid and
reliable instrument to assess foot and ankle related problems11).The aim of this study was to assess specifically the functional limitations caused by foot
involvement in patients with SpA.
SUBJECTS AND METHODS
Patients with AS and PsA aged 18–70 years, with foot pain for more than 4 weeks who
underwent anteroposterior (AP) and lateral (L) feet radiography were included into the
study. They met the modified New York criteria for AS and Moll-Wright criteria for PsA12, 13). Informed consent was obtained from all patients. Patients who had
flatfoot, previous foot surgery, or any other foot disorder unrelated to SpA, and who had a
systemic disease such as diabetes or hyperthyroidism were excluded. Ethical approval for
this study was obtained from the ethical committee of the university where the study was
conducted.The demographic features of subjects were determined. The clinical findings of foot
involvement were assessed by observing for swelling, redness, or tenderness. To obtain a
numerical value, a “clinical findings score” (CFS) was calculated by giving 1 point for
every finding on one foot [swelling: 1 point, redness: 1 point, tenderness: 1 point; the
maximum CFS score was 6 for the two feet]. The radiologic involvement of the foot was
evaluated by the spondyloarthropathy tarsal radiographic index (SpA-TRI), which is a valid
and reliable radiologic index developed specifically for the assessment of foot involvement
in SpA, and is suitable for use with two or more X-ray projections. It has five points; 0:
normal, 1: osteopenia or suspicious findings, 2: definite joint space narrowing, bony
erosions, periosteal whiskering, enthesophytes, 3: paraarticular enthesophytes/incomplete
bridging, 4: bony ankylosis/joint space fusion or complete bridging. The maximum SpA-TRI
score for the two feet (total SpA-TRI score) is 5614). Foot X-ray images were evaluated by a radiologist who had no
information about the clinical status of subjects. Talonavicular, calcaneocuboid,
intercuneiform, cuneonavicular, and subtalar joints, and the calcaneal attachments of the
Achilles tendon and plantar fascia (7 places) were assessed using the SpA-TRI.The foot-related functional status of patients was determined by the Turkish version of the
FAOS. It was a self-assessment questionnaire filled by patients themselves. FAOS is
calculated by a specific equation, and “100” indicates no problems while “0” indicates
extreme problems8). Since the pain
assessment was achieved in detail by FAOS, no other pain assessment scale was needed.C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were used as serum
markers for disease activity.Statistical analysis was done using Statistical Package for Social Studies, version 10.0.
Pearson correlation analysis was used to reveal the relationships between parameters.
RESULTS
Thirty patients with SpA (14 AS, 16 PsA) with a mean age of 49 years (range 26–70 years)
completed the study. The mean FAOS subscale scores were as follows: pain=58.70 ± 21.75,
symptoms=64.88 ± 26.05, ADL=66.27 ± 22.56, Sport-Rec=44.33 ± 26.42, and QoL=42.08 ± 24.99.
Pain subscale scores correlated positively with ADL, Sport-Rec, and QoL subscale scores.
Symptoms subscale score also positively correlated with ADL, Sport-Rec, and QoL subscale
scores (Table 1). Pain and symptoms subscale scores positively correlated with each other (r:
0.679, p<0.001).
Table 1.
Positive correlation between Pain and Symptoms subscale scores with other FAOS
subscale scores
ADL
Sport-Rec
QoL
Symptoms
r
0.749*
0.693*
0.552*
Pain
r
0.875*
0.872*
0.629*
FAOS: The Foot and Ankle Outcome Score, ADL: function in daily living, Sport-Rec:
functions in sport and recreation, QoL: quality of life. *p<0.01
FAOS: The Foot and Ankle Outcome Score, ADL: function in daily living, Sport-Rec:
functions in sport and recreation, QoL: quality of life. *p<0.01The mean CFS was 1.5 (0–4). This value demonstrated that although patients had foot pain,
they did not have prominent physical examination findings. The mean CRP and ESR were 1.1
(0.1–8.5) mg/dl and 32 (7–100) mm/h, respectively, showing low disease activity. There were
no relationships between FAOS subscale scores and CFS or serum markers (CRP/ ESR).The mean SpA-TRI score was 7.7 (0–24) and no correlation was found between FAOS subscale
scores and radiologic score.
DISCUSSION
Foot disorders may affect mobility and life quality significantly. AS frequently involves
the foot; the Achilles tendon is the second most common site of enthesitis after the
chondro-sternal junction, and the ankle is the second most common site for peripheral joint
disease after the knee6). The involvement
of the ankle and small joints of the foot is also frequent in PsA15). These effects of AS or PsA on the foot may lead to
functional limitations. The functional states and quality of life of patients with SpA are
usually evaluated using questionnaires such as BASFI, Health Assessment Questionnaire for
Spondyloarthropathies (HAQ-S), Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL),
or PsA-specific Quality of Life Questionnaire (PsAQoL)16,17,18,19). However, these
questionnaires evaluate the functional activities in a global manner without considering the
specific cause of the limitation. Therefore, the functional cost of foot involvement cannot
be assessed clearly with these indices leading to underestimation.FAOS is a 42-item questionnaire developed for the assessment of functional limitations
after ankle ligament reconstruction, but it was also used in other disorders affecting the
foot such as hallux valgus and rheumatoid arthritis7,8,9). It has 5 subscales; Pain, Symptoms, ADL, Sport-Rec, and QoL. Pain
subscale include 9 questions evaluating the frequency and severity of pain in certain
situations such as walking on flat surface or at night while in bed. Symptoms subscale has 7
questions assessing the stiffness, swelling, and movement properties of the foot/ankle. The
ADL and Sport-Rec subscales evaluate the degree of difficulty experienced due to foot/ankle
disorders in functional activities. The fifth subscale, QoL, focuses on the awareness of the
foot/ankle problem8, 11). Pain and symptoms subscale scores significantly and positively
correlated with each other and with ADL, Sport-Rec, and QoL subscale scores. Pain and
symptoms such as stiffness or range of motion loss, were the major cause of limitation of
functional activities in patients with SpA.Plain radiography is a routinely used imaging technique in the evaluation of radiologic
involvement in rheumatic diseases. SpA-TRI is the radiologic index developed specifically
for the assessment of foot involvement in SpA. In this study, no correlation was found
between SpA-TRI and FAOS subscale scores. The mean SpA-TRI score was 7, a very low score
when compared with the maximum score of 56. It could be speculated that although patients
had symptoms, radiography did not show the involvement clearly, and therefore, no
statistically significant results were obtained. The magnetic resonance imaging technique is
quite successful in demonstrating very early changes at the feet even in patients with
asymptomatic AS and PsA20, 21). Therefore, this should be the preferred technique for
future studies.In this study, the relationships between the FAOS subscale scores and CFS and serum markers
were also assessed. There were no relationships between FAOS subscale scores and CFS. The
foot is composed of small joints and their examination is relatively difficult than that of
the large joints. The inflammatory changes producing pain in these small joints may not
always lead to swelling, redness, or tenderness. These reasons may explain the lack of a
relationship between CFS and FAOS subscale scores. In our study, CRP and ESR values were
distributed in a wide range (0.1–8.5 mg/dl and 7–100 mm/h, respectively) showing that foot
involvement may not be directly affected from the disease activity. This hypothesis remains
to be clarified with studies having a larger sample size.In conclusion, rheumatic pain, resulting from the inflammatory changes in the joints and
related structures, is a very important clinical problem disturbing the mood, sleep, and
quality of life of patients22,23,24). It is the most
common presenting symptom of rheumatic diseases of the foot and may precede clinical and
radiologic findings25). This study
demonstrated that foot pain in patients with SpA might result in significant foot-related
functional limitation. Therefore, foot involvement and its functional results should be
evaluated separately regardless of the global functional state and disease activity of the
patient. To improve pain and function physical therapy modalities or orthosis may be
used26, 27). More studies about the foot involvement at the early and late
stages of the disease are needed and the possible treatment approaches must be
investigated.
Authors: L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain Journal: Ann Rheum Dis Date: 2003-01 Impact factor: 19.103
Authors: C Pacheco-Tena; J D Londoño; J Cazarín-Barrientos; A Martínez; J Vázquez-Mellado; J F Moctezuma; M A González; C Pineda; M H Cardiel; R Burgos-Vargas Journal: Ann Rheum Dis Date: 2002-04 Impact factor: 19.103
Authors: Lan Chen; Stephen Lyman; Huong Do; Jon Karlsson; Stephanie P Adam; Elizabeth Young; Jonathan T Deland; Scott J Ellis Journal: Foot Ankle Int Date: 2012-12 Impact factor: 2.827
Authors: Brina Xing Ying Erh; Hong-Gu He; Kate Frances Carter; Peter P Cheung; Daphne S Tan; Wenru Wang; Keith Rome Journal: J Foot Ankle Res Date: 2019-01-23 Impact factor: 2.303